In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae.
Antimicrob Agents Chemother
; 58(6): 3541-6, 2014 Jun.
Article
em En
| MEDLINE
| ID: mdl-24687491
ABSTRACT
We assessed the activity of tigecycline (TGC) combined with colistin (COL) against carbapenem-resistant enterobacteria. Synergy occurred in vitro against the majority of isolates, with the exception of Serratia marcescens. In a simple animal model (Galleria mellonella), TGC-COL was superior (P < 0.01) in treating Escherichia coli, Klebsiella pneumoniae, and Enterobacter infections, including those with TGC-COL resistance. Clinical studies are needed to determine whether TGC-COL regimens may be a viable option.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Colistina
/
Enterobacteriaceae
/
Infecções por Enterobacteriaceae
/
Minociclina
/
Antibacterianos
Limite:
Animals
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article